Senti Biosciences Holdings, Inc.
SNTI- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001854270
No open-market purchases or sales by Senti Biosciences Holdings, Inc. insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $6.37M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Senti Biosciences Holdings, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 16
- +3 vs. Q4 2025
- Shares held
- 5.64M
- +690.3K (+13.9%) vs. Q4 2025
- Total value
- $4.58M
- −$567.9K (−11.0%) vs. Q4 2025
- New holders
- 7
- 3 more added
- Sold out
- 4
- 1 more reduced
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SNTI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $6.37M |
| Q1 2026 | 16 | $4.58M |
| Q4 2025 | 15 | $5.84M |
| Q3 2025 | 16 | $8.27M |
| Q2 2025 | 15 | $14.2M |
| Q1 2025 | 16 | $19.9M |
| Q4 2024 | 16 | $3.23M |
| Q3 2024 | 14 | $2.41M |
| Q2 2024 | 20 | $2.17M |
| Q1 2024 | 27 | $4.15M |
| Q4 2023 | 25 | $7.56M |
| Q3 2023 | 26 | $5.02M |
| Q2 2023 | 28 | $7.64M |
| Q1 2023 | 24 | $14.3M |
| Q4 2022 | 26 | $16.6M |
| Q3 2022 | 23 | $27.8M |
| Q2 2022 | 20 | $22.1M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Senti Biosciences Holdings, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 1 | $1 | 0.00% | +1 | New |
| Morgan Stanley | 160 | $130 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 334 | $271 | 0.00% | −2−0.6% | Reduced |
| UBS Group AG | 8,637 | $7.01K | 0.00% | +4,108+90.7% | Added |
| State Street Corp | 10,010 | $8.13K | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 12,000 | $9.74K | 0.00% | +12,000 | New |
| HRT Financial LP | 14,844 | $12.0K | 0.00% | +14,844 | New |
| Northern Trust Corp | 16,778 | $13.6K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 17,277 | $14.0K | 0.00% | +17,277 | New |
| BlackRock, Inc. | 25,074 | $20.4K | 0.00% | +1,690+7.2% | Added |
| Menlo Ventures Management, L.P. | 35,737 | $29.0K | 0.01% | +35,737 | New |
| Vanguard Fiduciary Trust Co | 91,193 | $74.0K | 0.00% | +91,193 | New |
| Geode Capital Management, LLC | 207,043 | $168.1K | 0.00% | +62,246+43.0% | Added |
| Vanguard Capital Management LLC | 537,504 | $436.5K | 0.00% | +537,504 | New |
| Nantahala Capital Management, LLC | 888,000 | $721.1K | 0.05% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,775,615 | $3.07M | 0.17% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −44,409−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −38,427−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,411−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Msop GP, L.L.C. | – | – | – | – | Not filed |